President and Chief
Executive Officer
FY2024 saw increased sales and a significant rise in profits.Medium to long-term earnings will be driven by the healthcare and school DX businesses.
Thank you very much for your continued support and kindness.
In order to enhance its corporate value over the medium to long-term, the Group is aggressively working on the healthcare business and the school DX business, both of which are expected to expand in the future, with the aim of achieving sales and profit growth in both businesses.
Overview of financial results for FY2024
Increase in sales and significant increase in profit.Both healthcare and school DX businesses are performing well.
We have announced the financial results for the fiscal year ending September 2024 on November 7th.
Net sales increased compared to the previous fiscal year, primarily driven by growth in the healthcare business and corporate DX support services. Operating income saw a significant increase, thanks to the impact of higher sales and the control of SG&A expenses.
In the healthcare business, the number of stores adopting the cloud-based medication history system reached a record high on a quarterly basis. The number of municipalities implementing the childcare DX initiative also progressed smoothly. Additionally, in the school DX business, the number of schools adopting the full cloud-based school administration support system continued to expand steadily.
Consolidated business results (Period from October 1, 2023 to September 30, 2024)
|
FY2024 |
YoY | |
| Millions of yen | % | |
|
Net sales |
27,669 |
+3.2 |
|
Cost of sales |
7,264 |
(13.8) |
|
Gross profit |
20,404 |
+11.1 |
|
SG&A |
18,010 |
(0.4) |
|
Operating income |
2,394 |
+702.3 |
|
Ordinary income |
2,827 |
+516.7 |
|
Profit attribute to owners of parent |
2,363 |
+213.8 |
Basic policy in FY2025
For each business, we have established basic policies and priority issues, and we are working towards achieving our goals with a focus on driving sales and profit growth.
In the healthcare business, we aim to achieve further sales and profit growth.In the cloud-based medication history service, we will drive further sales growth by expanding the number of pharmacies adopting the system and enhancing the services offered. In the childcare DX business, we will promote our platform strategy.
In the school DX business, we also aim for further sales and profit growth.We will continue to expand the number of private schools adopting our system, while also focusing on strengthening our efforts to secure contracts with public schools.
In the content business, we will maintain the overall number of paid subscribers through the growth of security-related apps. Additionally, in the original comic business, we will increase the number of hit titles and ensure profitability across the entire segment.
Earning forecast for FY2025
Our earnings forecast for the fiscal year ending September 30, 2025, as in the previous year, is to focus on sales and profit growth in the healthcare and school DX businesses to boost overall earnings.
Image of medium to long-term profit
Regarding the future earnings picture, we expect the school DX business to contribute to profits most quickly in the short term.
In the mid to long-term, we believe the healthcare business will play a leading role. First, we will drive further sales and profit growth through the cloud-based medication history system and the childcare DX initiative. Then, by expanding the recurring revenue from each business, we aim to achieve “sustainable growth” across the entire group.
We hope that we can continue to count on your support as we pursue our initiatives.
November, 2024